Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine (The KSPN Migraine Study)
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2019
At a glance
- Drugs Ketorolac (Primary) ; Sumatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms KSPN
- 01 Sep 2015 According to an Egalet media release, data from this study will be presented at PainWeek 2015.
- 01 Sep 2015 Time frame for the endpoint changed from 1 year to 2 years according to ClinicalTrials.gov
- 23 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.